Veritaz
Veritaz is a private Indian pharmaceutical company headquartered in Hyderabad, founded in 2005, focused on anti-infective and pain-management therapeutic areas with a pipeline of products. It operates with 1,001–5,000 employees.
- Company typePrivate
- Founded2005
- HeadquartersHyderabad, India
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Veritaz firmographics
Firmographics- Name
- Veritaz
- Website
- https://veritaz.in
- Company type
- Private
- Founded year
- 2005
- Headcount range
- 1,001–5,000 employees
- Short description
- Veritaz is a private Indian pharmaceutical company headquartered in Hyderabad, founded in 2005, focused on anti-infective and pain-management therapeutic areas with a pipeline of products. It operates with 1,001–5,000 employees.
- Ownership category
- akta.pro rank
Veritaz industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN)
Keywords
Where Veritaz is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Markets served
Veritaz business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Veritaz product offering
Product offeringCore offering
Veritaz operates in the pharmaceutical sector, catering to anti-infective and pain-management therapeutic areas. The company maintains a pipeline of products in these therapeutic categories. No specific marketed products, formulations, or service offerings are disclosed in the available source data.
Differentiator
Problem solved
Functional benefit
Veritaz technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Veritaz competitors and assessment
Company assessmentDirect peers
- Lupin Limited: Indian pharma company with strong anti-infective franchise and growing specialty presence. Comparable in therapeutic mix and domestic plus export orientation.
- Mankind Pharma: Indian pharma major with significant presence in anti-infectives and pain management, plus a large domestic field force. Highly comparable therapeutic mix and go-to-market model to Veritaz.
- Alkem Laboratories: Indian pharma firm with material anti-infective and pain management portfolios across domestic and international markets. Similar size and therapeutic breadth to Veritaz.
- Cipla: One of India's largest anti-infective-focused pharmaceutical companies with global reach. Directly comparable on therapeutic focus and Indian generics distribution model.
- Glenmark Pharmaceuticals: India-based pharma with significant anti-infective and pain management franchises and emerging specialty pipeline. Comparable therapeutic positioning and pipeline-driven growth thesis.
- Unichem Laboratories: Indian pharma company with therapeutic focus overlapping anti-infectives and pain management. Comparable in size, therapeutic mix, and India-centric operations.
Broad incumbents
- Sun Pharmaceutical Industries: India's largest pharma company with extensive anti-infective franchise and substantial pain management presence. Sets the competitive ceiling in the categories Veritaz operates in.
- Aurobindo Pharma: Large Indian pharma with one of the broadest anti-infective portfolios globally. Comparable on therapeutic focus though larger in scale and geographic reach.
- Cadila Pharmaceuticals (Zydus): Large Indian pharma conglomerate with broad anti-infective and pain management offerings plus broader portfolios. Acts as a broader incumbent against which mid-size players like Veritaz compete.
- Dr. Reddy's Laboratories: India-headquartered global pharma with significant anti-infective presence and a Hyderabad base. Provides a relevant benchmark for Hyderabad-based growth orientation.
Market position
Customer concentration
Veritaz social profiles
Digital presenceVeritaz financial estimates
Financial estimateRevenue estimate
Valuation estimate
Veritaz leadership team
Management profileNumber of profiles
Veritaz funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Veritaz M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Veritaz
What does Veritaz do?
Veritaz operates in the pharmaceutical sector, catering to anti-infective and pain-management therapeutic areas. The company maintains a pipeline of products in these therapeutic categories. No specific marketed products, formulations, or service offerings are disclosed in the available source data.
When was Veritaz founded?
Veritaz was founded in 2005. It employs 1,001 to 5,000 people.
Where is Veritaz based?
Veritaz is headquartered in Hyderabad, India, in the Asia region.
Who are Veritaz's main competitors?
Direct peers on record are Lupin Limited, Mankind Pharma, Alkem Laboratories, Cipla, Glenmark Pharmaceuticals and Unichem Laboratories. Broad incumbents are Sun Pharmaceutical Industries, Aurobindo Pharma, Cadila Pharmaceuticals (Zydus) and Dr. Reddy's Laboratories.
Does Veritaz have an API?
No public API is recorded for Veritaz.
What industry is Veritaz in?
Veritaz's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAN, Pain Management & Anesthesiology Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.